HBL - Hadasit Bio-Holdings Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
HDST
IL0010954050
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 7.43M 2.05M |
---|---|---|---|---|---|
Net income 2022 | -31M -8.56M | Net income 2023 | -29M -8.01M | EV / Sales 2022 | - |
Net cash position 2022 | 12.93M 3.57M | Net cash position 2023 | 6.46M 1.78M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.46
x | P/E ratio 2023 |
-0.25
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 25% |
Managers | Title | Age | Since |
---|---|---|---|
Yoram Azulai
CEO | Chief Executive Officer | 63 | 15-09-19 |
Tamar Raz
CHM | Chairman | 61 | 14-05-17 |
Doron Cohen
AUD | Comptroller/Controller/Auditor | 53 | 15-08-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Doron Nevo
BRD | Director/Board Member | 68 | 18-07-28 |
Erez Meltzer
BRD | Director/Board Member | 67 | 16-07-04 |
Orit Stav
BRD | Director/Board Member | 53 | 17-10-31 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 46.56B | |
+45.38% | 41.67B | |
+0.69% | 41.16B | |
+30.52% | 32.4B | |
+22.30% | 28.18B | |
-6.35% | 28.1B | |
+49.25% | 14.52B | |
+49.18% | 13.74B | |
+3.45% | 12.17B |